All Stories

  1. Plank-Shaped Column-Forming Mesogens with Substituents on One Side Only
  2. Columnar Liquid-Crystalline Dinaphthoperylenetetracarboxdiimides
  3. One-dimensional coordination polymers of [Co3(dpa)4]2+ and [MF6]2− (M = ReIV, ZrIV and SnIV)
  4. Complementary Synthetic Approaches to Elongated Polycyclic Arenes with Regioisomeric Carboxylic Substitution Patterns
  5. From Chrysene to Double [5]Helicenes
  6. An “Intermediate Spin” Nickel Hydride Complex Stemming from Delocalized Ni2(μ-H)2Bonding
  7. Molecular Mechanism of Action of 2-Ferrocenyl-1,1-diphenylbut-1-ene on HL-60 Leukemia Cells
  8. Oxidative Stretching of Metal–Metal Bonds to Their Limits
  9. Correction to Helicenes from Diarylmaleimides
  10. Helicenes from Diarylmaleimides
  11. Switching off the single-molecule magnet properties of the [CoII(Me6tren)(OH2)]2+ module by complexation with trans-[RuIII(salen)(CN)2]−
  12. Ferrocenyl flavonoid-induced morphological modifications of endothelial cells and cytotoxicity against B16 murine melanoma cells
  13. Synthesis and Antiproliferative Effects of [3]Ferrocenophane Transposition Products and Pinacols Obtained from McMurry Cross-Coupling Reactions
  14. Cyanido-bridged one-dimensional systems assembled from [ReIVCl4(CN)2]2− and [MII(cyclam)]2+ (M = Ni, Cu) precursors
  15. Deciphering the Activation Sequence of Ferrociphenol Anticancer Drug Candidates
  16. A canted antiferromagnetic ordered phase of cyanido-bridged MnIII2ReIV single-chain magnets
  17. Ferrocenyl catechols: synthesis, oxidation chemistry and anti-proliferative effects on MDA-MB-231 breast cancer cells
  18. In vitro inhibitory properties of ferrocene-substituted chalcones and aurones on bacterial and human cell cultures
  19. Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs
  20. Synthesis and Structural Characterization of Ferrocenyl-Substituted Aurones, Flavones, and Flavonols
  21. Biological evaluation of twenty-eight ferrocenyl tetrasubstituted olefins: Cancer cell growth inhibition, ROS production and hemolytic activity
  22. Ferrocenyl chalcone difluoridoborates inhibit HIV-1 integrase and display low activity towards cancer and endothelial cells
  23. Bioorganometallics: Future Trends in Drug Discovery, Analytical Chemistry, and Catalysis†,‡
  24. Anodic properties of diarylethene derivatives having organometallic piano-stool tags
  25. Synthesis, Cytotoxicity, and COMPARE Analysis of Ferrocene and [3]Ferrocenophane Tetrasubstituted Olefin Derivatives against Human Cancer Cells
  26. Nature of Bonding in Complexes Containing “Supershort” Metal−Metal Bonds. Raman and Theoretical Study of M2(dmp)4[M = Cr (Natural Abundance Cr,50Cr, and54Cr) and Mo; dmp = 2,6-Dimethoxyphenyl]
  27. Synthesis of cytotoxic ferrocenyl flavones via a ferricenium-mediated 1,6-oxidative cyclization
  28. Facile synthesis and strong antiproliferative activity of disubstituted diphenylmethylidenyl-[3]ferrocenophanes on breast and prostate cancer cell lines
  29. Back matter
  30. Comparative toxicity of [3]ferrocenophane and ferrocene moieties on breast cancer cells
  31. Ferrocene Functionalized Endocrine Modulators as Anticancer Agents
  32. Ferrocenyl Quinone Methides as Strong Antiproliferative Agents: Formation by Metabolic and Chemical Oxidation of Ferrocenyl Phenols
  33. Further insights into hydrophobic interactions between ferrocenyl-tamoxifen drugs and non-polar molecular architectures at electrode surfaces
  34. A [3]Ferrocenophane Polyphenol Showing a Remarkable Antiproliferative Activity on Breast and Prostate Cancer Cell Lines
  35. The replacement of a phenol group by an aniline or acetanilide group enhances the cytotoxicity of 2-ferrocenyl-1,1-diphenyl-but-l-ene compounds against breast cancer cells
  36. Synthesis and Structure-Activity Relationships of Ferrocenyl Tamoxifen Derivatives with Modified Side Chains
  37. Synthesis, oxidation chemistry and cytotoxicity studies on ferrocene derivatives of diethylstilbestrol
  38. Structural and biological investigation of ferrocene-substituted 3-methylidene-1,3-dihydro-2H-indol-2-ones
  39. Role of aromatic substituents on the antiproliferative effects of diphenyl ferrocenyl butene compounds
  40. Antiparasitic and immunomodulatory activities of 1,1-bis(4-hydroxyphenyl)-2-phenyl-but-1-ene and its protected and free 2-ferrocenyl derivatives
  41. Ferrocenyl compounds possessing protected phenol and thiophenol groups: Synthesis, X-ray structure, and in vitro biological effects against breast cancer
  42. Electrochemical parameters and techniques in drug development, with an emphasis on quinones and related compounds
  43. Ferrocifens and Ferrocifenols as New Potential Weapons against Breast Cancer
  44. Organometallic analogues of tamoxifen: Effect of the amino side-chain replacement by a carbonyl ferrocenyl moiety in hydroxytamoxifen
  45. Organometallic diphenols: The importance of the organometallic moiety on the expression of a cytotoxic effect on breast cancer cells
  46. The influence of phenolic hydroxy substitution on the electron transfer and anti-cancer properties of compounds based on the 2-ferrocenyl-1-phenyl-but-1-ene motif
  47. The Presence of a Ferrocenyl Unit on an Estrogenic Molecule is Not Always Sufficient to Generate in vitro Cytotoxicity
  48. A Series of Unconjugated Ferrocenyl Phenols: Prospects as Anticancer Agents
  49. Metal complex SERMs (selective oestrogen receptor modulators). The influence of different metal units on breast cancer cell antiproliferative effects
  50. Ferrocene-Mediated Proton-Coupled Electron Transfer in a Series of Ferrocifen-Type Breast-Cancer Drug Candidates
  51. Modification of the Estrogenic Properties of Diphenols by the Incorporation of Ferrocene. Generation of Antiproliferative Effects in Vitro
  52. Selective Estrogen Receptor Modulators in the Ruthenocene Series. Synthesis and Biological Behavior
  53. New Chemistry of the Triply Bonded Divanadium (V24+) Unit and Reduction to an Unprecedented V23+Core
  54. Observation of Symmetry Lowering and Electron Localization in the Doublet-States of a Spin-Frustrated Equilateral Triangular Lattice:  Cu3(O2C16H23)·1.2C6H12
  55. Applications of High-Field (W-Band) EPR to M−M Bonded Units (M = Cr, Mo):  The First Confirmed Oxidation of a Cr24+Paddlewheel Complex to a Stable Isostructural Cr25+Product
  56. A Highly Reduced V23+Unit with a Metal−Metal Bond Order of 3.5
  57. EPR probing of bonding and spin localization of the doublet-quartet states in a spin-frustrated equilateral triangular lattice: Cu3(O2C16H23)6·1.2 C6H12
  58. Steps on the way to the first dirhodium tetracarboxylate with no axial ligation: synthetic lessons and a plethora of Rh2(O2CR)4L2−n compounds, n=0, 1, 2
  59. The First Dirhodium Tetracarboxylate Molecule without Axial Ligation:  New Insight into the Electronic Structures of Molecules with Importance in Catalysis and Other Reactions
  60. The Lengths of Molybdenum to Molybdenum Quadruple Bonds:  Correlations, Explanations, and Corrections
  61. Filling a Void:  Isolation and Characterization of Tetracarboxylato Dimolybdenum Cations
  62. Crystal structure and magnetic behavior of Cu3(O2C16H23)6·1.2 C6H12. An unexpected structure and an example of spin frustration
  63. After 155 Years, A Crystalline Chromium Carboxylate with a Supershort Cr−Cr Bond